Publications by authors named "Anna C Cooper"
J Adv Pract Oncol
November 2023
Article Synopsis
- Patients with metastatic HPV-associated oropharyngeal cancer often have a good survival rate of over 2 years but face limited treatment options after immunotherapy, prompting the exploration of capecitabine as a salvage therapy.
- A retrospective study investigated the outcomes of 10 patients who received capecitabine, primarily as a fourth-line treatment, with results showing a median survival of 10.5 months, and a clinical benefit rate of 70%.
- Findings suggest that capecitabine may provide extended benefits for some heavily pretreated patients, but further research is needed to identify predictive factors for response and to confirm its efficacy through larger studies.
